Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 204196
Company: SUN PHARM
Company: SUN PHARM
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE | DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE | 20MG;10MG | CAPSULE;ORAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 06/03/2026 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE
CAPSULE;ORAL; 20MG;10MG
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE | DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE | 20MG;10MG | CAPSULE;ORAL | Prescription | No | AB | 202934 | ACTAVIS ELIZABETH |
| DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE | DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE | 20MG;10MG | CAPSULE;ORAL | Prescription | No | AB | 218426 | HETERO LABS LTD III |
| DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE | DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE | 20MG;10MG | CAPSULE;ORAL | Prescription | No | AB | 204196 | SUN PHARM |
| NUEDEXTA | DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE | 20MG;10MG | CAPSULE;ORAL | Prescription | Yes | AB | 021879 | OTSUKA AMERICA PHARM |